Search
Animal Health and Animal Welfare at Boehringer Ingelheim
Animal Health Partnering Guide.pdf
Animal Health Partnering Outlook
Partnering with Animal Health MAY 2024 CORP_0.pdf
Oral_Health.pdf
Partnering_In_ORALHEALTH_0.pdf
Making More Health at a Glance.pdf
Partnering in Mental Health Disorders MAY 2024 CORP _0.pdf
Making More Health - CREATE - Magazine Social Entrepreneurship - Edition 2023
Partnering in Oral Health MAY 2024 CORP_0.pdf
BI-access-to-healthcare-strategy
public health
BI_Animal_Health.pdf
190326_BI_Beethoven_Infographic_Animal-Human-Health_Final.pdf
190326_BI_Beethoven_Infographic_Animal-Human-Health_Final.pdf
Boehringer Ingelheim Animal Health Business Unit Factsheet_2.pdf
Cat Health Booklet.pdf
ForBetterHealth.pdf
Approval for Aservo EquiHaler equine asthma therapy
Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
Three challenges shape future antiparasitic treatment
The three key challenges that will shape the future of antiparasitic treatment
GARC Louis Nel interview on global rabies control
GARC’s Executive Director Professor Louis Nel shares what it takes to fight rabies.
sustainably fighting rabies info hub
Did you know that every nine minutes, rabies takes a human life? Find out how we support the elimination of this deadly disease.
Launch of first veterinary vaccines produced in China
Swine vaccine Ingelvac PRRS MLV, produced by Boheringer Ingelheim veterinary vaccine manufacturing plant in Taizhou is now officially supplied to the China market.
Arti-cell Forte stem cell-based veterinary product
Boehringer Ingelheim launches the first-ever registered stem cell-based veterinary medicine